NasdaqGS - Delayed Quote USD

QuidelOrtho Corporation (QDEL)

Compare
38.68 -0.11 (-0.28%)
At close: October 25 at 4:00 PM EDT
38.06 -0.62 (-1.59%)
After hours: October 25 at 5:06 PM EDT

Research Analysis

Earnings Per Share

Consensus EPS
?

Revenue vs. Earnings

Revenue 637M
Earnings -147.7M
?

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
?

Analyst Price Targets

44.00
56.17 Average
38.68 Current
64.00 High

Earnings Estimate

CURRENCY IN USD Current Qtr. (Sep 2024)Next Qtr. (Dec 2024)Current Year (2024)Next Year (2025)
No. of Analysts 8888
Avg. Estimate 0.321.041.732.93
Low Estimate 0.220.841.512.26
High Estimate 0.431.161.963.25
Year Ago EPS 0.91.174.131.73

Revenue Estimate

CURRENCY IN USD Current Qtr. (Sep 2024)Next Qtr. (Dec 2024)Current Year (2024)Next Year (2025)
No. of Analysts 8888
Avg. Estimate 642.1M722.49M2.71B2.73B
Low Estimate 632.67M698.46M2.68B2.67B
High Estimate 653.26M737.02M2.74B2.81B
Year Ago Sales --742.6M3B2.71B
Sales Growth (year/est) ---2.70%-9.50%0.80%

Earnings History

CURRENCY IN USD 9/30/2023 12/31/2023 3/31/2024 6/30/2024
EPS Est. 0.62.050.39-0.23
EPS Actual 0.91.170.44-0.07
Difference 0.3-0.880.050.16
Surprise % 50.00%-42.90%12.80%69.60%

EPS Trend

CURRENCY IN USD Current Qtr. (Sep 2024)Next Qtr. (Dec 2024)Current Year (2024)Next Year (2025)
Current Estimate 0.321.041.732.93
7 Days Ago 0.321.041.732.93
30 Days Ago 0.321.061.753.01
60 Days Ago 0.311.071.753.17
90 Days Ago 0.461.171.963.36

EPS Revisions

CURRENCY IN USD Current Qtr. (Sep 2024)Next Qtr. (Dec 2024)Current Year (2024)Next Year (2025)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

CURRENCY IN USD QDELIndustrySectorS&P 500
Current Qtr. -64.40%----4.50%
Next Qtr. -11.10%----9.60%
Current Year -58.10%----2.10%
Next Year 69.40%----12.90%
Next 5 Years (per annum) 7.20%----11.76%
Past 5 Years (per annum) -3.58%------

Upgrades & Downgrades

Reiterates RBC Capital: Outperform to Outperform 8/16/2024
Reiterates RBC Capital: Outperform to Outperform 8/1/2024
Maintains RBC Capital: Outperform to Outperform 5/9/2024
Downgrade UBS: Neutral to Sell 3/4/2024
Downgrade Craig-Hallum: Buy to Hold 2/14/2024
Maintains RBC Capital: Outperform to Outperform 2/14/2024

Related Tickers